By Adam Bonislawski

Pressure BioSciences this week reported second-quarter revenue rose 49 percent to $402,104 from $270,381 year over year.

The rise in revenues came primarily from sales of consumables related to PBI's Pressure Cycling Technology Sample Preparation Systems and an increase in the number of PCT systems that were sold as opposed to leased during the quarter.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.